nodes	percent_of_prediction	percent_of_DWPC	metapath
Epinephrine—TNF—melanoma	0.384	1	CbGaD
Epinephrine—SLC22A5—Dactinomycin—melanoma	0.109	0.328	CbGbCtD
Epinephrine—CYP1A2—Carmustine—melanoma	0.0605	0.181	CbGbCtD
Epinephrine—CYP1A2—Vemurafenib—melanoma	0.0478	0.143	CbGbCtD
Epinephrine—CYP3A4—Temozolomide—melanoma	0.0457	0.137	CbGbCtD
Epinephrine—CYP1A2—Dacarbazine—melanoma	0.0366	0.11	CbGbCtD
Epinephrine—CYP3A4—Vemurafenib—melanoma	0.0251	0.0751	CbGbCtD
Epinephrine—CYP3A4—Docetaxel—melanoma	0.0086	0.0258	CbGbCtD
Epinephrine—Skin necrosis—Carmustine—melanoma	0.00295	0.0392	CcSEcCtD
Epinephrine—Hemiplegia—Carmustine—melanoma	0.00288	0.0384	CcSEcCtD
Epinephrine—Rales—Bleomycin—melanoma	0.00287	0.0383	CcSEcCtD
Epinephrine—Hemiplegia—Temozolomide—melanoma	0.00278	0.0371	CcSEcCtD
Epinephrine—Local reaction—Bleomycin—melanoma	0.00213	0.0283	CcSEcCtD
Epinephrine—Cerebral haemorrhage—Carmustine—melanoma	0.00186	0.0247	CcSEcCtD
Epinephrine—Cerebral haemorrhage—Temozolomide—melanoma	0.0018	0.0239	CcSEcCtD
Epinephrine—Necrosis—Dactinomycin—melanoma	0.0014	0.0186	CcSEcCtD
Epinephrine—Extravasation—Bleomycin—melanoma	0.00135	0.018	CcSEcCtD
Epinephrine—Necrosis—Carmustine—melanoma	0.00131	0.0175	CcSEcCtD
Epinephrine—Memory impairment—Temozolomide—melanoma	0.00127	0.0169	CcSEcCtD
Epinephrine—Extravasation—Dactinomycin—melanoma	0.00126	0.0168	CcSEcCtD
Epinephrine—Extravasation—Carmustine—melanoma	0.00118	0.0157	CcSEcCtD
Epinephrine—Skin exfoliation—Bleomycin—melanoma	0.00113	0.015	CcSEcCtD
Epinephrine—Drug interaction—Carmustine—melanoma	0.00111	0.0148	CcSEcCtD
Epinephrine—Supraventricular tachycardia—Docetaxel—melanoma	0.00101	0.0134	CcSEcCtD
Epinephrine—Skin exfoliation—Carmustine—melanoma	0.000983	0.0131	CcSEcCtD
Epinephrine—Disorientation—Bleomycin—melanoma	0.000957	0.0127	CcSEcCtD
Epinephrine—Skin exfoliation—Temozolomide—melanoma	0.00095	0.0126	CcSEcCtD
Epinephrine—Cerebrovascular accident—Bleomycin—melanoma	0.000873	0.0116	CcSEcCtD
Epinephrine—Erythema—Vemurafenib—melanoma	0.000851	0.0113	CcSEcCtD
Epinephrine—Necrosis—Docetaxel—melanoma	0.000843	0.0112	CcSEcCtD
Epinephrine—Myocardial ischaemia—Docetaxel—melanoma	0.000823	0.011	CcSEcCtD
Epinephrine—Extravasation—Docetaxel—melanoma	0.000758	0.0101	CcSEcCtD
Epinephrine—Isoprenaline—MAPK1—melanoma	0.00074	1	CrCbGaD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.000719	0.00957	CcSEcCtD
Epinephrine—Drug interaction—Docetaxel—melanoma	0.000713	0.00949	CcSEcCtD
Epinephrine—Nervous system disorder—Vemurafenib—melanoma	0.000681	0.00906	CcSEcCtD
Epinephrine—Hypokalaemia—Carmustine—melanoma	0.00068	0.00905	CcSEcCtD
Epinephrine—Skin disorder—Vemurafenib—melanoma	0.000674	0.00898	CcSEcCtD
Epinephrine—Blood pressure increased—Docetaxel—melanoma	0.000661	0.0088	CcSEcCtD
Epinephrine—Hypokalaemia—Temozolomide—melanoma	0.000657	0.00875	CcSEcCtD
Epinephrine—Acute coronary syndrome—Bleomycin—melanoma	0.00065	0.00865	CcSEcCtD
Epinephrine—Myocardial infarction—Bleomycin—melanoma	0.000647	0.00861	CcSEcCtD
Epinephrine—Skin exfoliation—Docetaxel—melanoma	0.000631	0.00841	CcSEcCtD
Epinephrine—Sweating increased—Temozolomide—melanoma	0.000608	0.00809	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Vemurafenib—melanoma	0.000599	0.00798	CcSEcCtD
Epinephrine—Haemoglobin—Bleomycin—melanoma	0.000595	0.00792	CcSEcCtD
Epinephrine—Haemorrhage—Bleomycin—melanoma	0.000592	0.00788	CcSEcCtD
Epinephrine—Lightheadedness—Docetaxel—melanoma	0.000592	0.00788	CcSEcCtD
Epinephrine—Hypoaesthesia—Bleomycin—melanoma	0.000589	0.00784	CcSEcCtD
Epinephrine—Pulmonary oedema—Docetaxel—melanoma	0.000589	0.00784	CcSEcCtD
Epinephrine—Hyperglycaemia—Carmustine—melanoma	0.000582	0.00775	CcSEcCtD
Epinephrine—Renal failure—Carmustine—melanoma	0.000566	0.00753	CcSEcCtD
Epinephrine—Hyperglycaemia—Temozolomide—melanoma	0.000563	0.00749	CcSEcCtD
Epinephrine—Flushing—Bleomycin—melanoma	0.00055	0.00731	CcSEcCtD
Epinephrine—Haemoglobin—Carmustine—melanoma	0.000519	0.00691	CcSEcCtD
Epinephrine—Haemorrhage—Carmustine—melanoma	0.000517	0.00688	CcSEcCtD
Epinephrine—Erythema—Bleomycin—melanoma	0.000515	0.00686	CcSEcCtD
Epinephrine—Hypoaesthesia—Carmustine—melanoma	0.000514	0.00684	CcSEcCtD
Epinephrine—Hallucination—Carmustine—melanoma	0.000514	0.00684	CcSEcCtD
Epinephrine—Flushing—Dactinomycin—melanoma	0.000513	0.00682	CcSEcCtD
Epinephrine—Renal impairment—Docetaxel—melanoma	0.000504	0.00672	CcSEcCtD
Epinephrine—Haemoglobin—Temozolomide—melanoma	0.000502	0.00668	CcSEcCtD
Epinephrine—Haemorrhage—Temozolomide—melanoma	0.000499	0.00665	CcSEcCtD
Epinephrine—Hallucination—Temozolomide—melanoma	0.000497	0.00661	CcSEcCtD
Epinephrine—Hypoaesthesia—Temozolomide—melanoma	0.000497	0.00661	CcSEcCtD
Epinephrine—Erythema—Dactinomycin—melanoma	0.000481	0.0064	CcSEcCtD
Epinephrine—Flushing—Carmustine—melanoma	0.00048	0.00638	CcSEcCtD
Epinephrine—Flushing—Temozolomide—melanoma	0.000464	0.00617	CcSEcCtD
Epinephrine—Arrhythmia—Carmustine—melanoma	0.000462	0.00615	CcSEcCtD
Epinephrine—Dizziness—Vemurafenib—melanoma	0.000459	0.00611	CcSEcCtD
Epinephrine—Mental disorder—Carmustine—melanoma	0.000453	0.00603	CcSEcCtD
Epinephrine—Erythema—Carmustine—melanoma	0.00045	0.00599	CcSEcCtD
Epinephrine—Vomiting—Vemurafenib—melanoma	0.000441	0.00588	CcSEcCtD
Epinephrine—Chest pain—Bleomycin—melanoma	0.000439	0.00584	CcSEcCtD
Epinephrine—Mental disorder—Temozolomide—melanoma	0.000438	0.00582	CcSEcCtD
Epinephrine—Erythema—Temozolomide—melanoma	0.000435	0.00579	CcSEcCtD
Epinephrine—Agitation—Carmustine—melanoma	0.000413	0.0055	CcSEcCtD
Epinephrine—Nausea—Vemurafenib—melanoma	0.000412	0.00549	CcSEcCtD
Epinephrine—Agitation—Temozolomide—melanoma	0.0004	0.00532	CcSEcCtD
Epinephrine—Hypertension—Carmustine—melanoma	0.000388	0.00517	CcSEcCtD
Epinephrine—Palpitations—Temozolomide—melanoma	0.000384	0.00511	CcSEcCtD
Epinephrine—Chest pain—Carmustine—melanoma	0.000383	0.0051	CcSEcCtD
Epinephrine—Paraesthesia—Bleomycin—melanoma	0.000378	0.00503	CcSEcCtD
Epinephrine—Hypertension—Temozolomide—melanoma	0.000375	0.005	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000368	0.00489	CcSEcCtD
Epinephrine—Acute coronary syndrome—Docetaxel—melanoma	0.000365	0.00485	CcSEcCtD
Epinephrine—Renal failure—Docetaxel—melanoma	0.000364	0.00484	CcSEcCtD
Epinephrine—Myocardial infarction—Docetaxel—melanoma	0.000363	0.00483	CcSEcCtD
Epinephrine—Tachycardia—Carmustine—melanoma	0.000358	0.00477	CcSEcCtD
Epinephrine—Nervous system disorder—Temozolomide—melanoma	0.000348	0.00463	CcSEcCtD
Epinephrine—Skin disorder—Temozolomide—melanoma	0.000345	0.00459	CcSEcCtD
Epinephrine—Hyperhidrosis—Temozolomide—melanoma	0.000343	0.00457	CcSEcCtD
Epinephrine—Haemoglobin—Docetaxel—melanoma	0.000334	0.00444	CcSEcCtD
Epinephrine—Haemorrhage—Docetaxel—melanoma	0.000332	0.00442	CcSEcCtD
Epinephrine—Insomnia—Carmustine—melanoma	0.000332	0.00442	CcSEcCtD
Epinephrine—Hypoaesthesia—Docetaxel—melanoma	0.00033	0.0044	CcSEcCtD
Epinephrine—Paraesthesia—Carmustine—melanoma	0.00033	0.00439	CcSEcCtD
Epinephrine—Somnolence—Carmustine—melanoma	0.000326	0.00435	CcSEcCtD
Epinephrine—Insomnia—Temozolomide—melanoma	0.000321	0.00427	CcSEcCtD
Epinephrine—Paraesthesia—Temozolomide—melanoma	0.000319	0.00424	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Carmustine—melanoma	0.000317	0.00422	CcSEcCtD
Epinephrine—Somnolence—Temozolomide—melanoma	0.000315	0.0042	CcSEcCtD
Epinephrine—Flushing—Docetaxel—melanoma	0.000308	0.0041	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Temozolomide—melanoma	0.000306	0.00408	CcSEcCtD
Epinephrine—Arrhythmia—Docetaxel—melanoma	0.000297	0.00395	CcSEcCtD
Epinephrine—Mental disorder—Docetaxel—melanoma	0.000291	0.00387	CcSEcCtD
Epinephrine—Erythema—Docetaxel—melanoma	0.000289	0.00385	CcSEcCtD
Epinephrine—Vomiting—Bleomycin—melanoma	0.000267	0.00356	CcSEcCtD
Epinephrine—Palpitations—Docetaxel—melanoma	0.000256	0.0034	CcSEcCtD
Epinephrine—Nausea—Bleomycin—melanoma	0.00025	0.00333	CcSEcCtD
Epinephrine—Hypertension—Docetaxel—melanoma	0.00025	0.00332	CcSEcCtD
Epinephrine—Vomiting—Dactinomycin—melanoma	0.000249	0.00332	CcSEcCtD
Epinephrine—Chest pain—Docetaxel—melanoma	0.000246	0.00328	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000244	0.00325	CcSEcCtD
Epinephrine—Dizziness—Carmustine—melanoma	0.000243	0.00323	CcSEcCtD
Epinephrine—Dizziness—Temozolomide—melanoma	0.000235	0.00312	CcSEcCtD
Epinephrine—Vomiting—Carmustine—melanoma	0.000233	0.00311	CcSEcCtD
Epinephrine—Nausea—Dactinomycin—melanoma	0.000233	0.0031	CcSEcCtD
Epinephrine—Nervous system disorder—Docetaxel—melanoma	0.000231	0.00308	CcSEcCtD
Epinephrine—Tachycardia—Docetaxel—melanoma	0.00023	0.00307	CcSEcCtD
Epinephrine—Skin disorder—Docetaxel—melanoma	0.000229	0.00305	CcSEcCtD
Epinephrine—Vomiting—Temozolomide—melanoma	0.000226	0.003	CcSEcCtD
Epinephrine—Nausea—Carmustine—melanoma	0.000218	0.0029	CcSEcCtD
Epinephrine—Insomnia—Docetaxel—melanoma	0.000213	0.00284	CcSEcCtD
Epinephrine—Paraesthesia—Docetaxel—melanoma	0.000212	0.00282	CcSEcCtD
Epinephrine—Nausea—Temozolomide—melanoma	0.000211	0.00281	CcSEcCtD
Epinephrine—Somnolence—Docetaxel—melanoma	0.00021	0.00279	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Docetaxel—melanoma	0.000204	0.00271	CcSEcCtD
Epinephrine—Dizziness—Docetaxel—melanoma	0.000156	0.00208	CcSEcCtD
Epinephrine—Vomiting—Docetaxel—melanoma	0.00015	0.002	CcSEcCtD
Epinephrine—Nausea—Docetaxel—melanoma	0.00014	0.00187	CcSEcCtD
Epinephrine—ADRA2A—Metabolism—PIK3CB—melanoma	3.45e-06	1.67e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—ABCB1—melanoma	3.45e-06	1.67e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—IL2—melanoma	3.45e-06	1.67e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—IGF1—melanoma	3.45e-06	1.67e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—CCND1—melanoma	3.44e-06	1.67e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—MAPK1—melanoma	3.43e-06	1.66e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—IL6—melanoma	3.43e-06	1.66e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—EGFR—melanoma	3.43e-06	1.66e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—PTGS2—melanoma	3.42e-06	1.66e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—CXCL8—melanoma	3.42e-06	1.66e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—FGF2—melanoma	3.41e-06	1.65e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—CCND1—melanoma	3.41e-06	1.65e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—CTNNB1—melanoma	3.4e-06	1.65e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—HRAS—melanoma	3.39e-06	1.64e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—CTNNB1—melanoma	3.37e-06	1.64e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—GNAQ—melanoma	3.37e-06	1.63e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—CD44—melanoma	3.37e-06	1.63e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—CCND1—melanoma	3.36e-06	1.63e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—CXCL8—melanoma	3.36e-06	1.63e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—HRAS—melanoma	3.34e-06	1.62e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—MMP9—melanoma	3.34e-06	1.62e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—CDKN1B—melanoma	3.34e-06	1.62e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—MAP2K1—melanoma	3.33e-06	1.62e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—CTNNB1—melanoma	3.33e-06	1.61e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—CDKN1A—melanoma	3.33e-06	1.61e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—PTEN—melanoma	3.32e-06	1.61e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—PIK3CD—melanoma	3.31e-06	1.61e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—MMP9—melanoma	3.31e-06	1.6e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—NFKB1—melanoma	3.3e-06	1.6e-05	CbGpPWpGaD
Epinephrine—ADRA2C—GPCR downstream signaling—AKT1—melanoma	3.3e-06	1.6e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—CDKN1A—melanoma	3.3e-06	1.6e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—VEGFA—melanoma	3.29e-06	1.59e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—PTEN—melanoma	3.29e-06	1.59e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—CDKN1B—melanoma	3.28e-06	1.59e-05	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR downstream signaling—PIK3CA—melanoma	3.28e-06	1.59e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—NFKB1—melanoma	3.27e-06	1.59e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—CASP3—melanoma	3.27e-06	1.58e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—MMP9—melanoma	3.27e-06	1.58e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—IL2—melanoma	3.26e-06	1.58e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—STAT3—melanoma	3.26e-06	1.58e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—CDKN1A—melanoma	3.25e-06	1.58e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—NRAS—melanoma	3.25e-06	1.57e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—IL6—melanoma	3.25e-06	1.57e-05	CbGpPWpGaD
Epinephrine—ADRA1B—GPCR downstream signaling—AKT1—melanoma	3.25e-06	1.57e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—PTEN—melanoma	3.25e-06	1.57e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—KRAS—melanoma	3.24e-06	1.57e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—AKT1—melanoma	3.24e-06	1.57e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—CYP1B1—melanoma	3.23e-06	1.57e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—NFKB1—melanoma	3.23e-06	1.57e-05	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—AKT1—melanoma	3.22e-06	1.56e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—CASP3—melanoma	3.22e-06	1.56e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—IL2—melanoma	3.21e-06	1.56e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—AKT1—melanoma	3.21e-06	1.55e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—PIK3CA—melanoma	3.21e-06	1.55e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—IL6—melanoma	3.2e-06	1.55e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—MDM2—melanoma	3.19e-06	1.55e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—CCND1—melanoma	3.18e-06	1.54e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—PRKCA—melanoma	3.18e-06	1.54e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—FGF2—melanoma	3.17e-06	1.54e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—AKT1—melanoma	3.17e-06	1.53e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—CTNNB1—melanoma	3.15e-06	1.53e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—ERCC2—melanoma	3.15e-06	1.53e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—ERBB2—melanoma	3.15e-06	1.53e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—CCND1—melanoma	3.13e-06	1.52e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—MAPK3—melanoma	3.11e-06	1.51e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—PIK3CB—melanoma	3.11e-06	1.51e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—CTNNB1—melanoma	3.1e-06	1.5e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—MMP9—melanoma	3.09e-06	1.5e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—CDKN1A—melanoma	3.08e-06	1.49e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—PTEN—melanoma	3.07e-06	1.49e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—NFKB1—melanoma	3.06e-06	1.48e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	3.05e-06	1.48e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—MMP9—melanoma	3.04e-06	1.47e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—CDKN1A—melanoma	3.03e-06	1.47e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—MYC—melanoma	3.03e-06	1.47e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—PTEN—melanoma	3.02e-06	1.47e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—NFKB1—melanoma	3.01e-06	1.46e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—VEGFA—melanoma	3e-06	1.45e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—AKT1—melanoma	3e-06	1.45e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CXCL8—melanoma	2.99e-06	1.45e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—PTEN—melanoma	2.98e-06	1.45e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—PIK3CA—melanoma	2.98e-06	1.44e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—VEGFA—melanoma	2.97e-06	1.44e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—STAT3—melanoma	2.97e-06	1.44e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—MDM2—melanoma	2.97e-06	1.44e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—HRAS—melanoma	2.97e-06	1.44e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—MAPK1—melanoma	2.96e-06	1.44e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—NRAS—melanoma	2.96e-06	1.43e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—EGFR—melanoma	2.96e-06	1.43e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—AKT1—melanoma	2.95e-06	1.43e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—STAT3—melanoma	2.94e-06	1.43e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—NRAS—melanoma	2.93e-06	1.42e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—VEGFA—melanoma	2.93e-06	1.42e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—ERBB2—melanoma	2.93e-06	1.42e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CDKN1B—melanoma	2.92e-06	1.41e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—PIK3CG—melanoma	2.91e-06	1.41e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—STAT3—melanoma	2.9e-06	1.41e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—NRAS—melanoma	2.9e-06	1.4e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—PIK3CB—melanoma	2.89e-06	1.4e-05	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR downstream signaling—AKT1—melanoma	2.88e-06	1.4e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CASP3—melanoma	2.86e-06	1.39e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—IL2—melanoma	2.85e-06	1.38e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—IL6—melanoma	2.84e-06	1.38e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—MAPK3—melanoma	2.84e-06	1.37e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—MAPK3—melanoma	2.81e-06	1.36e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—PPARG—melanoma	2.81e-06	1.36e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—KRAS—melanoma	2.8e-06	1.36e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CCND1—melanoma	2.78e-06	1.35e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CXCL8—melanoma	2.77e-06	1.34e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—VEGFA—melanoma	2.77e-06	1.34e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—MAPK3—melanoma	2.77e-06	1.34e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—MYC—melanoma	2.76e-06	1.34e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—HRAS—melanoma	2.76e-06	1.34e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CTNNB1—melanoma	2.75e-06	1.34e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—STAT3—melanoma	2.75e-06	1.33e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—NRAS—melanoma	2.74e-06	1.33e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—MYC—melanoma	2.73e-06	1.32e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—VEGFA—melanoma	2.73e-06	1.32e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CDKN1B—melanoma	2.71e-06	1.31e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—STAT3—melanoma	2.7e-06	1.31e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—MMP9—melanoma	2.7e-06	1.31e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—MAPK1—melanoma	2.7e-06	1.31e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—MYC—melanoma	2.7e-06	1.31e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—EGFR—melanoma	2.7e-06	1.31e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—NRAS—melanoma	2.7e-06	1.31e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CDKN1A—melanoma	2.69e-06	1.3e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—PTEN—melanoma	2.69e-06	1.3e-05	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR downstream signaling—AKT1—melanoma	2.68e-06	1.3e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—MAPK1—melanoma	2.67e-06	1.3e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—EGFR—melanoma	2.67e-06	1.3e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—NFKB1—melanoma	2.67e-06	1.3e-05	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—PIK3CA—melanoma	2.66e-06	1.29e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—ABCB1—melanoma	2.66e-06	1.29e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CASP3—melanoma	2.66e-06	1.29e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—IL2—melanoma	2.65e-06	1.29e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—MAPK1—melanoma	2.64e-06	1.28e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—EGFR—melanoma	2.64e-06	1.28e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—IL6—melanoma	2.64e-06	1.28e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—MAPK3—melanoma	2.62e-06	1.27e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—AKT1—melanoma	2.62e-06	1.27e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.61e-06	1.26e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—PIK3CA—melanoma	2.59e-06	1.26e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CCND1—melanoma	2.58e-06	1.25e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—MAPK3—melanoma	2.58e-06	1.25e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—PIK3CA—melanoma	2.57e-06	1.25e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CTNNB1—melanoma	2.56e-06	1.24e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—PIK3CD—melanoma	2.56e-06	1.24e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—MYC—melanoma	2.55e-06	1.24e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—KRAS—melanoma	2.55e-06	1.23e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—ALB—melanoma	2.53e-06	1.22e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—KRAS—melanoma	2.52e-06	1.22e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—MYC—melanoma	2.51e-06	1.22e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—MMP9—melanoma	2.51e-06	1.22e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CDKN1A—melanoma	2.5e-06	1.21e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—MAPK1—melanoma	2.5e-06	1.21e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—EGFR—melanoma	2.5e-06	1.21e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—PTEN—melanoma	2.49e-06	1.21e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—KRAS—melanoma	2.49e-06	1.21e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—PIK3CG—melanoma	2.49e-06	1.21e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—TP53—melanoma	2.49e-06	1.2e-05	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—PIK3CA—melanoma	2.48e-06	1.2e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—NFKB1—melanoma	2.48e-06	1.2e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—MAPK1—melanoma	2.46e-06	1.19e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—EGFR—melanoma	2.46e-06	1.19e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—PRKCA—melanoma	2.45e-06	1.19e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—AKT1—melanoma	2.43e-06	1.18e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—ERCC2—melanoma	2.43e-06	1.18e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—VEGFA—melanoma	2.43e-06	1.18e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—STAT3—melanoma	2.4e-06	1.16e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—PPARG—melanoma	2.4e-06	1.16e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—NRAS—melanoma	2.4e-06	1.16e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—HRAS—melanoma	2.38e-06	1.15e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—KRAS—melanoma	2.36e-06	1.14e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—PIK3CA—melanoma	2.34e-06	1.13e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—KRAS—melanoma	2.32e-06	1.12e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—PIK3CA—melanoma	2.32e-06	1.12e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—MAPK3—melanoma	2.29e-06	1.11e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—PIK3CA—melanoma	2.29e-06	1.11e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—IL6—melanoma	2.28e-06	1.1e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—TP53—melanoma	2.26e-06	1.1e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—VEGFA—melanoma	2.25e-06	1.09e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—TP53—melanoma	2.24e-06	1.09e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—MYC—melanoma	2.23e-06	1.08e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—STAT3—melanoma	2.23e-06	1.08e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—PIK3CB—melanoma	2.23e-06	1.08e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—NRAS—melanoma	2.23e-06	1.08e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—TP53—melanoma	2.22e-06	1.07e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—PTGS2—melanoma	2.21e-06	1.07e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—PIK3CD—melanoma	2.19e-06	1.06e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—MAPK1—melanoma	2.18e-06	1.06e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—EGFR—melanoma	2.18e-06	1.06e-05	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—AKT1—melanoma	2.18e-06	1.05e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—PIK3CA—melanoma	2.17e-06	1.05e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—HRAS—melanoma	2.17e-06	1.05e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—ALB—melanoma	2.16e-06	1.05e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—HRAS—melanoma	2.15e-06	1.04e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—PIK3CA—melanoma	2.13e-06	1.03e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—MAPK3—melanoma	2.13e-06	1.03e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—HRAS—melanoma	2.12e-06	1.03e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—AKT1—melanoma	2.12e-06	1.03e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—PIK3CA—melanoma	2.1e-06	1.02e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—AKT1—melanoma	2.1e-06	1.02e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—TP53—melanoma	2.1e-06	1.02e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—MYC—melanoma	2.07e-06	1e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—IL6—melanoma	2.07e-06	1e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—TP53—melanoma	2.06e-06	1e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—KRAS—melanoma	2.06e-06	9.99e-06	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—IL6—melanoma	2.05e-06	9.96e-06	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—AKT1—melanoma	2.03e-06	9.83e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—MAPK1—melanoma	2.03e-06	9.83e-06	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—IL6—melanoma	2.03e-06	9.83e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—EGFR—melanoma	2.03e-06	9.83e-06	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—HRAS—melanoma	2e-06	9.72e-06	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—HRAS—melanoma	1.97e-06	9.56e-06	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—PTEN—melanoma	1.93e-06	9.34e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—PIK3CG—melanoma	1.92e-06	9.3e-06	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—IL6—melanoma	1.92e-06	9.3e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—KRAS—melanoma	1.92e-06	9.28e-06	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—AKT1—melanoma	1.91e-06	9.27e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—PIK3CB—melanoma	1.91e-06	9.24e-06	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—AKT1—melanoma	1.9e-06	9.18e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—PIK3CA—melanoma	1.89e-06	9.18e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—PTGS2—melanoma	1.89e-06	9.15e-06	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—IL6—melanoma	1.89e-06	9.15e-06	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—AKT1—melanoma	1.87e-06	9.07e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—PPARG—melanoma	1.85e-06	8.98e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—TP53—melanoma	1.83e-06	8.88e-06	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—AKT1—melanoma	1.77e-06	8.58e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—PIK3CA—melanoma	1.76e-06	8.53e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—HRAS—melanoma	1.75e-06	8.49e-06	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—AKT1—melanoma	1.74e-06	8.44e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—AKT1—melanoma	1.72e-06	8.33e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—TP53—melanoma	1.7e-06	8.25e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—PIK3CD—melanoma	1.69e-06	8.18e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—IL6—melanoma	1.68e-06	8.13e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—ALB—melanoma	1.67e-06	8.07e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—PTEN—melanoma	1.65e-06	7.98e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—HRAS—melanoma	1.63e-06	7.89e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—IL6—melanoma	1.56e-06	7.55e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—AKT1—melanoma	1.55e-06	7.5e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—PIK3CB—melanoma	1.47e-06	7.13e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—PTGS2—melanoma	1.46e-06	7.06e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—AKT1—melanoma	1.44e-06	6.97e-06	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—PIK3CA—melanoma	1.36e-06	6.59e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—PTEN—melanoma	1.27e-06	6.16e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—PIK3CA—melanoma	1.16e-06	5.63e-06	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—AKT1—melanoma	1.11e-06	5.38e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—AKT1—melanoma	9.49e-07	4.6e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—PIK3CA—melanoma	8.97e-07	4.35e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—AKT1—melanoma	7.33e-07	3.55e-06	CbGpPWpGaD
